Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26FML0D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,192
Award facts
- Contract value 100% obligated
- $20,192.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20,192.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Wegovy 2.4 mg/0.75 mL pen injections, with a completion date of February 3, 2026. This non-set-aside contract was competitively awarded and represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. The IDC serves as a comprehensive pharmaceutical supply vehicle enabling AmerisourceBergen to deliver a wide range of brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare systems. The Wegovy delivery under this task order will be fulfilled from the company's Conshohocken location and supports the Defense Health Agency's medical supply chain requirements. As a leading pharmaceutical distributor competing on a full and open basis, AmerisourceBergen demonstrates significant capability in meeting federal procurement needs across multiple therapeutic domains, including diabetes and obesity management treatments such as the Wegovy product specified in this delivery order.
Quick answers
Who was awarded contract SPE2DR26FML0D?
SPE2DR26FML0D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 2, 2026.
How much is contract SPE2DR26FML0D worth?
The government has obligated $20,192 on SPE2DR26FML0D.
Is contract SPE2DR26FML0D an order under another contract?
Yes. SPE2DR26FML0D is a delivery order under SPE2DR25D1200, an indefinite delivery contract.
Was contract SPE2DR26FML0D competed?
The extent of competition for SPE2DR26FML0D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award